Évolution du traitement de sortie après hospitalisation pour syndrome coronaire aigu en France entre 1995 et 2000 : données des études Usik 1995, Prévenir 1 et 2 et Usic 2000 (Q57658557)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Évolution du traitement de sortie après hospitalisation pour syndrome coronaire aigu en France entre 1995 et 2000 : données des études Usik 1995, Prévenir 1 et 2 et Usic 2000	article

Statements

scholarly article

0 references

Évolution du traitement de sortie après hospitalisation pour syndrome coronaire aigu en France entre 1995 et 2000 : données des études Usik 1995, Prévenir 1 et 2 et Usic 2000 (English)

0 references

hospitalization

1 reference

based on heuristic

inferred from title

author name string

N Danchin

1

0 references

G Hanania

2

0 references

O Grenier

3

0 references

L Vaur

4

0 references

E Amelineau

5

0 references

P Guéret

6

0 references

D Blanchard

7

0 references

J Ferrières

8

0 references

N Genès

9

0 references

J.-M Lablanche

10

0 references

C Cantet

11

0 references

J.-P Cambou

12

0 references

publication date

January 2003

0 references

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Annales de Cardiologie et d'Angeiologie

0 references

52

0 references

1

0 references

1-6

0 references

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Epidemiology of myocardial infarction in France: Therapeutic and prognostic implications of heart failure during the acute phase

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

[Efficacy of early reperfusion therapy at the acute stage of myocardial infarction in elderly patients: the USIK database]

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Caractéristiques initiales et prise en charge thérapeutique des sujets jeunes (âge inférieur à 45 ans) hospitalisés pour syndrome coronaire aigu : résultats des études françaises PRÉVENIR 1 et PRÉVENIR 2

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Optimizing the prescription of statins after an acute coronary syndrome: the influence of coronary angioplasty and total cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0003-3928(02)00181-6

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57658557&oldid=1984063779"